IAFF Center of Excellence Behavioral Health Trt and Recovery

IAFF Center of Excellence Behavioral Health Trt and Recovery

Services:
Transitional Services
• Outcome follow-up after discharge
• Aftercare/continuing care
• Naloxone and overdose education
• Discharge Planning

Age Groups Accepted

• Young Adults
• Adults

Pharmacotherapies

• Buprenorphine with naloxone
• Naltrexone (extended-release, injectable)
• Buprenorphine (extended-release, injectable)
• Naltrexone (oral)
• Disulfiram
• Non-nicotine smoking/tobacco cessation
• Medication for mental disorders
• Nicotine replacement
• Clonidine
• Acamprosate (Campral®)
• Buprenorphine without naloxone

Treatment Approaches

• Trauma-related counseling
• Cognitive behavioral therapy
• Motivational interviewing
• Anger management
• Relapse prevention
• Substance use disorder counseling
• 12-step facilitation

External Opioid Medications Source

• In-network prescribing entity

Detoxification (medical withdrawal) Services

• Medication routinely used during detoxification
• Alcohol Detoxification
• Opioids detoxification
• Methamphetamines detoxification
• Benzodiazepines Detoxification
• Cocaine Detoxification

Recovery Support Services

• Self-help groups
• Mentoring/peer support

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Group counseling
• Hepatitis education, counseling, or support
• Family counseling
• Individual counseling
• Smoking/vaping/tobacco cessation counseling
• Marital/couples counseling
• Substance use disorder education
• HIV or AIDS education, counseling, or support

Gender Accepted

• Male
• Female

Facility Smoking Policy

• Smoking permitted in designated area

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Type of Opioid Treatment

• Accepts clients using MAT but prescribed elsewhere
• Prescribes naltrexone
• Relapse prevention with naltrexone
• Lofexidine or Clonidine detoxification
• Buprenorphine detoxification
• Prescribes buprenorphine

Other Services

• Treatment for other addiction disorder

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Assessment/Pre-treatment

• Screening for substance use
• Complete medical history/physical exam
• Screening for mental disorders
• Comprehensive substance use assessment
• Comprehensive mental health assessment
• Outreach to persons in the community
• Screening for tobacco use

Ancillary Services

• Case management service
• Suicide prevention services
• Mental health services
• Integrated primary care services

Payment/Insurance/Funding Accepted

• Private health insurance
• Cash or self-payment

Special Programs/Groups Offered

• Clients who have experienced trauma
• Clients with co-occurring mental and substance use disorders
• Adult women
• Adult men

License/Certification/Accreditation

• State mental health department
• The Joint Commission

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient
• Regular outpatient treatment
• Outpatient day treatment or partial hospitalization
• Residential detoxification
• Short-term residential
• Residential/24-hour residential
• Intensive outpatient treatment
• Long-term residential

Facility Vaping Policy

• Vaping not permitted

Type of Care

• Detoxification
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Testing

• Testing for Hepatitis B (HBV)
• HIV testing
• Testing for Hepatitis C (HCV)
• Breathalyzer or blood alcohol testing
• STD testing
• Metabolic syndrome monitoring
• TB screening
• Drug or alcohol urine screening

Medical Services

• Hepatitis B (HBV) vaccination
• Hepatitis A (HAV) vaccination